Antiseptic Use and Dressing Application

Sponsor
Maternite Regionale Universitaire (Other)
Overall Status
Completed
CT.gov ID
NCT00389558
Collaborator
(none)
453
1
2
25
18.1

Study Details

Study Description

Brief Summary

The purposes of the study are:
  1. To compare the local efficacy (skin colonization) of 2 commercialized antiseptics used for the disinfection of the dressing application for an epicutaneocavous catheter (EPI).

  2. To evaluate whether the bacteria responsible for nosocomial infection is comparable to the flora diagnosed at the EPI site.

Condition or Disease Intervention/Treatment Phase
  • Procedure: disinfection efficacy using Biseptine
  • Procedure: disinfection efficacy using Amukin
Phase 4

Detailed Description

Epicutaneocavous catheter is a significant risk factor for nosocomial infection in newborn infants. These infections have been related to local bacterial colonisation. Therefore thorough disinfection should lower the risk of nosocomial infection. However, the local efficacy of antiseptic use has not yet been clearly evaluated in this situation.

Study Design

Study Type:
Interventional
Actual Enrollment :
453 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Comparison of Amukin Versus Biseptine Use for Dressing Application of Epicutaneocavous Catheters for Nosocomial Infection Prevention
Study Start Date :
Sep 1, 2006
Actual Primary Completion Date :
Sep 1, 2008
Actual Study Completion Date :
Oct 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 2

Biseptine

Procedure: disinfection efficacy using Biseptine
Detersion and antiseptic application when changing catheter dressing
Other Names:
  • Biseptine
  • Active Comparator: 1

    Amukin

    Procedure: disinfection efficacy using Amukin
    Detersion and antiseptic application when changing catheter dressing
    Other Names:
  • Amukin
  • Outcome Measures

    Primary Outcome Measures

    1. Efficacy on skin colonization of two commercially available antiseptics [2 weeks]

    Secondary Outcome Measures

    1. In case of nosocomial infection, relationship with skin bacteria [2 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 3 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All infants admitted to the Neonatal Intensive Care Unit

    • Epicutaneocavous catheter insertion indication

    Exclusion Criteria:
    • Epicutaneocavous catheter not inserted within the Unit

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Maternite Regionale Universitaire Nancy France 54042

    Sponsors and Collaborators

    • Maternite Regionale Universitaire

    Investigators

    • Study Director: Jean-Michel HASCOET, MD, University of NANCY, France
    • Principal Investigator: Monique LUX, Pharmacist, Maternite Regionale Universitaire

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00389558
    Other Study ID Numbers:
    • MRAP190406
    First Posted:
    Oct 19, 2006
    Last Update Posted:
    Sep 21, 2009
    Last Verified:
    Sep 1, 2009

    Study Results

    No Results Posted as of Sep 21, 2009